FdaApplication
NDA 208694
Identifiers
- fda_app_no: NDA208694
Properties
| Property | Value |
|---|---|
| applicant_name | HARROW EYE LLC |
| application_type | NDA |
| approval_date | 2017-05-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | EQ 0.24% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product